Cross-species study shows that Type 2 diabetes drug metformin could change the way childhood brain injury is treated
$3 million investment to initiate answers to key questions that will transform health care
Discovery to provide insights into liver development and disease progression
Weekly webinar series for trainees to cover key concepts in translation and commercialization of regenerative medicine.
A team of researchers led by scientists at the University of Toronto has delayed the onset of amyotrophic lateral sclerosis (ALS) in mice. They are cautiously optimistic that this research, which was funded in part by a Medicine by Design 2018 New Ideas Award, combined with other clinical advances, points to a potential treatment for ALS in humans.
Thirty-one research projects at U of T and its affiliated hospitals selected for funding to contribute to the global fight against the novel coronavirus.
Scientists can now edit multiple sites in the genome at the same time to learn how different DNA stretches co-operate in health and disease.
Medicine by Design is expanding its regenerative medicine research portfolio with the addition of four multi-disciplinary, multi-institution projects. “These team projects build on Medicine by Design’s successes over its first three years and will strengthen the University of Toronto and its affiliated hospitals as a global centre for regenerative medicine,” said Michael Sefton, executive director of Medicine by Design.
Tiny artificial intelligence (AI)-controlled robots could in the future be tasked with finding and capturing rare stem cells from brain tissue for therapy. While this type of microsurgery can take years to develop, Cindi Morshead and Aaron Wheeler have received a funding boost to make it happen.
U of T professor recognized for his accomplishments in tissue engineering
'Your research will have a transformational impact on how we treat many common diseases, such as stroke, diabetes and liver failure, creating better health outcomes for all Canadians,' Bains tells annual symposium
Projects to advance stem cell and gene therapy, enhance understanding of how the body repairs itself, and generate new technologies that will propel the field for decades
The project, part of the Human Cell Atlas, seeks to build a more complete map of the human liver and is a “direct extension” of the work the Toronto team has already done with support from Medicine by Design
Professor Shulamit Levenberg will serve as Medicine by Design’s first Scholar in Residence from July 15 to August 15, 2019.
More than 40 academics, clinicians, policy-makers and industry leaders from Canada and the U.K. participated in the Challenges in the Adoption of Regenerative Medicine Therapies (CHART) workshop on June 24 and 25, 2019.
